Regarding the PERK branch of the UPR, we found significantly increased phosphorylation of eIF2α on serine 51 in AD patients, which was not accompanied by changes in the levels of the transcription factor ATF4 (Figure 4I–J). Here, EIF2A is linked to Alzheimer disease.